Summary of a systematic literature review of Positive Airway Pressure device use and cancer risk
DreamStation

Jul 25, 2022

Summary of a systematic literature review of Positive Airway Pressure device use and cancer risk

Estimated reading time: 1-3 minutes

Philips Respironics engaged external scientific experts to perform an independent systematic literature review of epidemiological studies to evaluate whether use of Continuous or Bilevel Positive Airway Pressure (PAP) devices increases the risk of cancer in obstructive sleep apnea (OSA) patients.

Based on 13 epidemiological studies identified from the systematic literature review, no association has been established between use of PAP devices, including Philips Respironics PAP devices, and risk of cancer in patients with OSA. Two rigorous independent studies showed no statistical difference in cancer risk between OSA patients who used Philips Respironics PAP devices versus other brands of PAP devices. Eleven other epidemiological studies provided little additional insight into this question, but their results generally suggested no excess risk of cancer associated with PAP use for OSA.

The complete summary of the systematic literature review can be found here.

Share on social media

  • https://www.philips.com/a-w/about/news/archive/standard/news/articles/2022/20220725-summary-of-a-systematic-literature-review-of-positive-airway-pressure-device-use-and-cancer-risk.html Link copied

Topics

Contact

Steve Klink

Steve Klink

Philips Global Press Office

Tel: +31 6 10888824

You are about to visit a Philips global content page

Continue

Related news

You are about to visit a Philips global content page

Continue

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.